Related Experiment Video
Updated: Oct 21, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
Petra Mlcochova1,2, Steven A Kemp1,2,3, Mahesh Shanker Dhar4
1Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant shows reduced sensitivity to neutralizing antibodies and compromised vaccine effectiveness. Continued infection control measures are crucial, even after vaccination, to manage this highly transmissible variant.
Area of Science:
- Virology
- Immunology
- Epidemiology
Background:
- The B.1.617.2 (Delta) variant of SARS-CoV-2 emerged in India, outcompeting earlier strains like Alpha and Kappa.
- The Delta variant exhibits increased transmissibility and immune evasion properties compared to previous SARS-CoV-2 lineages.
Purpose of the Study:
- To evaluate the in vitro characteristics of the Delta variant, including its sensitivity to neutralizing antibodies and replication efficiency.
- To assess the effectiveness of vaccines against the Delta variant in a real-world healthcare setting.
Main Methods:
- In vitro assays using pseudotyped viruses to assess neutralization by antibodies from recovered individuals and vaccinees.
- Organoid and human airway epithelial models to compare replication efficiency between Delta and other variants.
- Analysis of vaccine effectiveness in healthcare workers infected during a period of mixed lineage circulation.
Main Results:
- The Delta variant demonstrated significantly reduced sensitivity to neutralizing antibodies from both recovered individuals and vaccinees compared to the wild-type.
- Delta exhibited higher replication efficiency in airway models and more efficient syncytium formation than other variants.
- Analysis indicated reduced effectiveness of the ChAdOx1 vaccine against the Delta variant compared to non-Delta strains.
Conclusions:
- The Delta variant's immune evasion and enhanced replication contribute to its dominance.
- Compromised vaccine efficacy against the Delta variant underscores the need for ongoing infection control measures.
- Further research is needed to understand the full implications of Delta variant infection on vaccine effectiveness and public health strategies.
Related Concept Videos
Viruses with RNA Genomes
Viral Mutations
Viral Recombination
Viral Replication: Lytic Cycle
Leaky Scanning
Size and Structure of Viral Genomes

